SLC28A1 inhibits clear cell renal cell carcinoma progression by affecting arachidonic acid metabolism: A novel nucleoside transporter-based targeted therapy strategy
Open Access
- 6 April 2026
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 649, 218481
Abstract
No abstract availableKeywords
Funding Information
- Key Project of Application Development Plan of Chongqing City (cstc2019jscx-gksbx0007)
This publication has 59 references indexed in Scilit:
- Amino acid metabolic reprogramming in clear cell renal cell carcinoma: Pathogenic mechanisms and therapeutic targetingCancer Letters, 2026
- D-mannose suppresses HIF-1α mediated metabolic reprogramming in clear cell renal cell carcinomaDiscover Oncology, 2025
- Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical TreatmentAdvances in Nutrition, 2023
- Intracellular Formation of Hemicyanine Nanoparticle Enhances Tumor‐Targeting Photoacoustic Imaging and Photothermal TherapyAdvanced Healthcare Materials, 2023
- Reactive oxygen species and DNA damage response in cancer2021
- Cross-talk between TLR4 and PPARγ pathways in the arachidonic acid-induced inflammatory response in pancreatic aciniThe International Journal of Biochemistry & Cell Biology, 2015
- Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumorVirchows Archiv, 2015
- Arachidonic acid hydroperoxide stimulates lipid peroxidation in rat liver nuclei and chromatin fractionsMolecular and Cellular Biochemistry, 2006
- The equilibrative nucleoside transporter family, SLC29Pflügers Archiv - European Journal of Physiology, 2004
- Polyunsaturated fatty acids, inflammation, and immunityLipids, 2001